Characterization of cord blood natural killer cells: Implications for transplantation and neonatal infections

Pediatric Research

Volumn 57, Issue 5 I, 2005, Pages 649-655

  Dalle, Jean Hugues ^a,b   Menezes, José ^a   Wagner, Éric ^a   Blagdon, Marie ^a   Champagne, Josette ^a   Champagne, Martin A ^a   Duval, Michel ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Hôpital Sainte Justine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CELL ANTIGEN; GAMMA INTERFERON; GRANZYME B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 15; INTERLEUKIN 2; L SELECTIN; PERFORIN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINE PRODUCTION; CYTOTOXICITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NEWBORN; NEWBORN INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UMBILICAL CORD BLOOD;

ANTIGENS, CD56; ANTIGENS, CD57; ANTIGENS, CD8; CELL PROLIFERATION; CELL TRANSPLANTATION; CYTOKINES; FETAL BLOOD; FLOW CYTOMETRY; GRANZYMES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-15; INTERLEUKIN-2; KILLER CELLS, NATURAL; L-SELECTIN; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; PHENOTYPE; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, INTERLEUKIN-2; SERINE ENDOPEPTIDASES;

EID: 17744367418     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000156501.55431.20     Document Type: Article

References (43)

1. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA 2002 Natural killer cell receptors: new biology and insights into the graft versus leukemia effect. Blood 100:1935-1948
2. Adkins B, Leclerc C, Marshall-Clarke S 2004 Neonatal adaptive immunity comes of age. Nat Rev Immunol 4:553-564
3. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A 2002 Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295:2097-2100
4. Giebel S, Locatelli FW, Lamparelli T, Velardi A, Davies SM, Frumento G, Maccario R, Bonetti F, Wojnar J, Martinetti M, Frassoni F, Giorgiani G, Bacigalupo A, Holowiecki J 2003 Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102:814-819
5. Dalle JH, Duval M, Moghrabi A, Wagner E, Vachon MF, Barrette S, Bernstein M, Champagne J, David M, Demers J, Rousseau P, Winikoff R, Champagne MA 2004 Results of un unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 33:605-611
6. Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E 2000 Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 342:1846-1854
7. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte JP, Fernandez M, Chastang C 1997 Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337:373-381
8. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR, Berkowitz RL, Cabbad M, Dobrila NL, Taylor PE, Rosenfield RE, Stevens CE 1998 Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339:1565-1577
9. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE 2001 Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97:2957-2961
10. Theilgaard-Monch K, Raaschou-Jensen K, Palm H, Schjodt K, Heilmann C, Vindelov L, Jacobsen N, Dickmeiss E 2001 Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 28:1073-1082
11. bright subset. Blood 97:3146-3151
12. Fehniger TA, Caligiuri MA 2001 Ontogeny and expansion of human natural killer cells: clinical implications. Int Rev Immunol 20:503-534
13. Nagler A, Lanier LL, Cwirla S, Phillips JH 1989 Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143:3183-3191
14. Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, Ritz J 1992 Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol 22:1-6
15. Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith KA, Ritz J 1990 Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 171:1509-1526
16. Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE 1992 CD16- CD56+ natural killer cells after bone marrow transplantation. Blood 79:3239-3244
17. Andre P, Spertini O, Guia S, Rihet P, Dignat-George F, Brailly H, Sampol J, Anderson PJ, Vivier E 2000 Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc Natl Acad Sci USA 97:3400-3405
18. dim natural killer cell subsets. J Immunol 161:400-408
19. Voss SD, Daley J, Ritz J, Robertson MJ 1998 Participation of the CD94 receptor complex in costimulation of human natural killer cells. J Immunol 160:1618-1626
20. Tanaka H, Kai S, Yamaguchi M, Misawa M, Fujimori Y, Yamamoto M, Hara H 2003 Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur J Haematol 71:29-38
21. Kubota A, Kubota S, Lohwasser S, Mager DL, Takei F 1999 Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol 163:212-216
22. Qian JX, Lee SM, Suen Y, Knoppel E, van de Ven C, Cairo MS 1997 Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 90:3106-3117
23. Webb BJ, Bochan MR, Montel A, Padilla LM, Brahmi Z 1994 The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol 159:246-261
24. Fawaz LM, Sharif-Askari E, Menezes J 1999 Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Immunol 163:4473-4480
25. Hasbold J, Gett AV, Rush JS, Deenick E, Avery D, Jun J, Hodgkin PD 1999 Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol 77:516-522
26. Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B 1996 Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J Exp Med 184:1845-1856
27. Leitner A, Strobl H, Fischmeister G, Kurz M, Romanakis K, Haas OA, Printz D, Buchinger P, Bauer S, Gadner H, Fritsch G 1996 Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood. Br J Haematol 92:255-262
28. Gardiner CM, Meara AO, Reen DJ 1998 Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood 91:207-213
29. Joyner JL, Augustine NH, Taylor KA, La Pine TR, Hill HR 2000 Effects of group B streptococci on cord and adult mononuclear cell interleukin-12 and interferon-gamma mRNA accumulation and protein secretion. J Infect Dis 182:974-977
30. Sancho L, de la Hera A, Casas J, Vaquer S, Martinez C, Alvarez-Mon M 1991 Two different maturational stages of natural killer lymphocytes in human newborn infants. J Pediatr 119:446-454
31. Lau AS, Sigaroudinia M, Yeung MC, Kohl S 1996 Interleukin-12 induces interferon-gamma expression and natural killer cytotoxicity in cord blood mononuclear cells. Pediatr Res 39:150-155
32. Lin SJ, Yan DC 2000 ICAM-1 (CD54) expression on T lymphocytes and natural killer cells from umbilical cord blood: regulation with interleukin-12 and interleukin-15. Cytokines Cell Mol Ther 6:161-164
33. Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL 2003 Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198:1201-1212
34. White GP, Watt PM, Holt BJ, Holt PG 2002 Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J Immunol 168:2820-2827
35. Hermann E, Truyens C, Alonso-Vega C, Even J, Rodriguez P, Berthe A, Gonzalez-Merino E, Torrico F, Carlier Y 2002 Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 100:2153-2158
36. Giraud P, Thuret I, Reviron D, Chambost H, Brunet C, Novakovitch G, Farnarier C, Michel G 2000 Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplant 25:53-57
37. Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D, Kotylo P, Brahmi Z, Smith FO 2000 Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 96:2703-2711
38. Klein AK, Patel DD, Gooding ME, Sempowski GD, Chen BJ, Liu C, Kurtzberg J, Haynes BF, Chao NJ 2001 T-Cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 7:454-466
39. Sonntag J, Brandenburg U, Polzehl D, Strauss E, Vogel M, Dudenhausen JW, Obladen M 1998 Complement system in healthy term newborns: reference values in umbilical cord blood. Pediatr Dev Pathol 1:131-135
40. Carr R 2000 Neutrophil production and function in newborn infants. Br J Haematol 110:18-28
41. Marshall-Clarke S, Reen D, Tasker L, Hassan J 2000 Neonatal immunity: how well has it grown up? Immunol Today 21:35-41
42. Suri M, Harrison L, Van de Ven C, Cairo MS 2003 Immunotherapy in the prophylaxis and treatment of neonatal sepsis. Curr Opin Pediatr 15:155-160
43. Tran P, Ahmad R, Xu J, Ahmad A, Menezes J 2003 Host's innate immune response to fungal and bacterial agents in vitro: up-regulation of interleukin-15 gene expression resulting in enhanced natural killer cell activity. Immunology 109:263-270